MicroRNA Era: The importance for diagnosis and prognosis of adrenocortical tumors

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Bezerra, João Evangelista ^a   Latronico, Ana Claudia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LOCKED NUCLEIC ACID; MICRORNA; MICRORNA 10; MICRORNA 100; MICRORNA 1202; MICRORNA 125B; MICRORNA 139 3P; MICRORNA 15; MICRORNA 16; MICRORNA 181B; MICRORNA 184; MICRORNA 195; MICRORNA 21; MICRORNA 210; MICRORNA 214; MICRORNA 335; MICRORNA 34A; MICRORNA 375; MICRORNA 483 3P; MICRORNA 483 5P; MICRORNA 503; MICRORNA 511; MICRORNA 675; UNCLASSIFIED DRUG;

ADRENAL CORTEX TUMOR; AREA UNDER THE CURVE; BLOOD SAMPLING; CANCER PROGNOSIS; CARCINOGENESIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; RECEIVER OPERATING CHARACTERISTIC; REVIEW; TUMOR DIAGNOSIS; TUMOR SUPPRESSOR GENE; ADRENAL CORTEX NEOPLASMS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PROGNOSIS;

ADRENAL CORTEX NEOPLASMS; CARCINOGENESIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PROGNOSIS;

EID: 84904089431     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/381917     Document Type: Review

References (59)

1. Kloos R. T., Gross M. D., Francis I. R., Korobkin M., Shapiro B., Incidentally discovered adrenal masses. Endocrine Reviews 1995 16 4 460 484 2-s2.0-0029114047
2. Thompson G. B., Young W. F., Adrenal incidentaloma. Current Opinion in Oncology 2003 15 1 84 90 2-s2.0-0037252556 10.1097/00001622-200301000-00013 (Pubitemid 36135653)
3. Wajchenberg B. L., Albergaria Pereira M. A., Medonca B. B., Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000 88 4 711 736 (Pubitemid 30091090)
4. Roman S., Adrenocortical carcinoma. Current Opinion in Oncology 2006 18 1 36 42 2-s2.0-33646683536 10.1097/01.cco.0000198976.43992.14 (Pubitemid 43740448)
5. Dackiw A. P. B., Lee J. E., Gagel R. F., Evans D. B., Adrenal cortical carcinoma. World Journal of Surgery 2001 25 7 914 926 2-s2.0-0034915765 10.1007/s00268-001-0030-7 (Pubitemid 32666394)
6. Luton J.-P., Cerdas S., Billaud L., Thomas G., Guilhaume B., Bertagna X., Laudat M.-H., Louvel A., Chapuis Y., Blondeau P., Bonnin A., Bricaire H., Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. The New England Journal of Medicine 1990 322 17 1195 1201 2-s2.0-0025248241 (Pubitemid 20137851)
7. Crucitti F., Bellantone R., Ferrante A., Boscherini M., Crucitti P., Carbone G., Casaccia M., Campisi C., Cavallaro A., Sapienza P., Del Gaudio A., Solidoro G., Dettori G., Marogna P., Di Giovanni V., Colli R., Doglietto G., Gozzetti G., Maldarizzi F., The italian registry for adrenal cortical carcinoma: analysis of a multiinstitutional series of 129 patients. Surgery 1996 119 2 161 170 2-s2.0-0029670955 10.1016/S0039-6060(96)80164-4 (Pubitemid 26052933)
8. Vassilopoulou-Sellin R., Schultz P. N., Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer 2001 92 5 1113 1121 (Pubitemid 32861659)
9. Icard P., Goudet P., Charpenay C., Andreassian B., Carnaille B., Chapuis Y., Cougard P., Henry J., Proye C., Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group. World Journal of Surgery 2001 25 7 891 897 2-s2.0-0034917097 10.1007/s00268-001-0047-y (Pubitemid 32666390)
10. Michalkiewicz E., Sandrini R., Figueiredo B., Miranda E. C. M., Caran E., Oliveira-Filho A. G., Marques R., Pianovski M. A. D., Lacerda L., Cristofani L. M., Jenkins J., Rodriguez-Galindo C., Ribeiro R. C., Clinical and outcome characteristics of children with adrenocortical tumors: a report from the international pediatric adrenocortical tumor registry. Journal of Clinical Oncology 2004 22 5 838 845 2-s2.0-1542713361 10.1200/JCO.2004.08.085 (Pubitemid 41103595)
11. Stewart J. N., Flageole H., Kavan P., A surgical approach to adrenocortical tumors in children: the mainstay of treatment. Journal of Pediatric Surgery 2004 39 5 759 763 2-s2.0-2442577110 10.1016/j.jpedsurg.2004. 01.029 (Pubitemid 38637930)
12. Weiss L. M., Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. American Journal of Surgical Pathology 1984 8 3 163 169 2-s2.0-0021350092 (Pubitemid 14166767)
13. van Slooten H., Schaberg A., Smeenk D., Moolenaar A. J., Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 1985 55 4 766 773 2-s2.0-0021966841 (Pubitemid 15173514)
14. Hough A. J., Hollified J. W., Page D. L., Hartmann W. H., Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. American Journal of Clinical Pathology 1979 72 3 390 399 2-s2.0-0018719716 (Pubitemid 10231372)
15. Weiss L. M., Medeiros L. J., Vickery A. L. Jr., Pathologic features of prognostic significance in adrenocortical carcinoma. American Journal of Surgical Pathology 1989 13 3 202 206 2-s2.0-0024513504 (Pubitemid 19081702)
16. Papotti M., Libè R., Duregon E., Volante M., Bertherat J., Tissier F., The Weiss score and beyond-histopathology for adrenocortical carcinoma. Hormones and Cancer 2011 2 6 333 340 2-s2.0-83555176378 10.1007/s12672-011-0088- 0
17. Aubert S., Wacrenier A., Leroy X., Devos P., Carnaille B., Proye C., Wemeau J. L., Lecomte-Houcke M., Leteurtre E., Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. American Journal of Surgical Pathology 2002 26 12 1612 1619 2-s2.0-0036892571 10.1097/00000478-200212000-00009 (Pubitemid 35387224)
18. Wieneke J. A., Thompson L. D. R., Heffess C. S., Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. American Journal of Surgical Pathology 2003 27 7 867 881 2-s2.0-0038579264 10.1097/00000478-200307000-00001 (Pubitemid 36758889)
19. Mendonca B. B., Lucon A. M., Menezes C. A. V., Saldanha L. B., Latronico A. C., Zerbini C., Madureira G., Domenice S., Albergaria M. A. P., Camargo M. H. A., Halpern A., Liberman B., Arnhold I. J. P., Bloise W., Andriolo A., Nicolau W., Silva F. A. Q., Wroclaski E., Arap S., Wajchenberg B. L., Clinical, hormonal and pathological findings in a comparative study of adrenocortical neoplasms in childhood and adulthood. Journal of Urology 1995 154 6 2004 2009 2-s2.0-0028785439 10.1016/S0022-5347(01)66673-4
20. Fassnacht M., Allolio B., Clinical management of adrenocortical carcinoma. Best Practice and Research: Clinical Endocrinology and Metabolism 2009 23 2 273 289 2-s2.0-66149163113 10.1016/j.beem.2008.10.008
21. Allolio B., Fassnacht M., Clinical review: adrenocortical carcinoma: clinical update. Journal of Clinical Endocrinology and Metabolism 2006 91 6 2027 2037 2-s2.0-33744952176 10.1210/jc.2005-2639 (Pubitemid 43854976)
22. Weiss L. M., Bertagna X., Chrousos G. P., Kawashima A., Kleihues P., Koch C. A., Giordano T. J., Medeiros L. J., Merino M. J., Ordonez N. G., Sasano H., Delellis R., Adrenal cortical carcinoma. Pathology and Genetics: Tumours of Endocrine Tumors 2004 World Health Organization
23. Fassnacht M., Johanssen S., Quinkler M., Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification. Cancer 2009 115 2 243 250
24. Wooten M. D., King D. K., Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 1993 72 11 3145 3155 (Pubitemid 23356754)
25. Schulick R. D., Brennan M. F., Adrenocortical carcinoma. World Journal of Urology 1999 17 1 26 34 2-s2.0-0033069954
26. Haak H. R., Hermans J., Van de Velde C. J. H., Lentjes E. G. W. M., Goslings B. M., Fleuren G.-J., Krans H. M. J., Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. British Journal of Cancer 1994 69 5 947 951 2-s2.0-0028208020 (Pubitemid 24140681)
27. Williamson S. K., Lew D., Miller G. J., Balcerzak S. P., Baker L. H., Crawford E. D., Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study. Cancer 2000 88 5 1159 1165 (Pubitemid 30127678)
28. Baudin E., Pellegriti G., Bonnay M., Penfornis A., Laplanche A., Vassal G., Schlumberger M., Impact of monitoring plasma 1, 1- dichlorodiphenildichloroethane (o, p′DDD) levels on the treatment of patients with adrenocortical carcinoma. Cancer 2001 92 6 1385 1392 (Pubitemid 32947821)
29. Hermsen I. G., Fassnacht M., Terzolo M., Houterman S., Den Hartigh J., Leboulleux S., Daffara F., Berruti A., Chadarevian R., Schlumberger M., Allolio B., Haak H. R., Baudin E., Plasma concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study. Journal of Clinical Endocrinology and Metabolism 2011 96 6 1844 1851 2-s2.0-79956306619 10.1210/jc.2010-2676
30. Fassnacht M., Terzolo M., Allolio B., Combination chemotherapy in advanced adrenocortical carcinoma. The New England Journal of Medicine 2012 366 23 2189 2197
31. Wortmann S., Quinkler M., Ritter C., Kroiss M., Johanssen S., Hahner S., Allolio B., Fassnacht M., Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma. European Journal of Endocrinology 2010 162 2 349 356 2-s2.0-75149143015 10.1530/EJE-09-0804
32. Quinkler M., Hahner S., Wortmann S., Johanssen S., Adam P., Ritte C., Strasburger C., Allolio B., Fassnacht M., Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine. Journal of Clinical Endocrinology and Metabolism 2008 93 6 2057 2062 2-s2.0-45149110737 10.1210/jc.2007-2564 (Pubitemid 351831515)
33. Kroiss M., Quinkler M., Johanssen S., Van Erp N. P., Lankheet N., Pöllinger A., Laubner K., Strasburger C. J., Hahner S., Müller H., Allolio B., Fassnacht M., Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial. Journal of Clinical Endocrinology and Metabolism 2012 97 10 3495 3503 2-s2.0-84867255648 10.1210/jc.2012-1419
34. Fraenkel M., Gueorguiev M., Barak D., Salmon A., Grossman A. B., Gross D. J., Everolimus therapy for progressive adrenocortical cancer. Endocrine 2013 44 1 187 192 2-s2.0-84881127351 10.1007/s12020-013-9878-1
35. Carthew R. W., Sontheimer E. J., Origins and mechanisms of miRNAs and siRNAs. Cell 2009 136 4 642 655 2-s2.0-60149088848 10.1016/j.cell.2009.01.035
36. Calin G. A., Croce C. M., MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 2006 25 46 6202 6210 2-s2.0-33749516448 10.1038/sj.onc.1209910 (Pubitemid 44527851)
37. Calin G. A., Dumitru C. D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., Croce C. M., Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 2002 99 24 15524 15529 2-s2.0-18744396337 10.1073/pnas.242606799 (Pubitemid 35403967)
38. Calin G. A., Ferracin M., Cimmino A., A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. The New England Journal of Medicine 2005 353 17 1793 1801 (Pubitemid 41549891)
39. Lu J., Getz G., Miska E. A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B. L., Mak R. H., Ferrando A. A., Downing J. R., Jacks T., Horvitz H. R., Golub T. R., MicroRNA expression profiles classify human cancers. Nature 2005 435 7043 834 838 2-s2.0-20444460289 10.1038/nature03702 (Pubitemid 40839735)
40. Cho W. C. S., MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. International Journal of Biochemistry and Cell Biology 2010 42 8 1273 1281 2-s2.0-77954386364 10.1016/j.biocel.2009.12.014
41. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Zhang Y., Wang J., Jiang X., Xiang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Wang J., Zen K., Zhang J., Zhang C., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 2008 18 10 997 1006 2-s2.0-53349177819 10.1038/cr.2008.282
42. Li J., Smyth P., Flavin R., Cahill S., Denning K., Aherne S., Guenther S. M., O'Leary J. J., Sheils O., Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnology 2007 7, article 36 2-s2.0-34447506198 10.1186/1472-6750-7-36 (Pubitemid 47065165)
43. Mraz M., Malinova K., Mayer J., Pospisilova S., MicroRNA isolation and stability in stored RNA samples. Biochemical and Biophysical Research Communications 2009 390 1 1 4 2-s2.0-70349952140 10.1016/j.bbrc.2009.09.061
44. Shen J., Stass S. A., Jiang F., MicroRNAs as potential biomarkers in human solid tumors. Cancer Letters 2013 329 2 125 136 2-s2.0-84872496432 10.1016/j.canlet.2012.11.001
45. Cai X., Cullen B. R., The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA 2007 13 3 313 316 2-s2.0-33847271696 10.1261/rna.351707 (Pubitemid 46327534)
46. Herbet M., Feige J. J., Thomas M., Insights into the role of genetic alterations in adrenocortical tumorigenesis. Molecular and Cellular Endocrinology 2009 300 1-2 169 174 2-s2.0-59649123557 10.1016/j.mce.2008.10.010
47. Tömböl Z., Szabó P. M., Molnár V., Wiener Z., Tölgyesi G., Horányi J., Riesz P., Reismann P., Patócs A., Likó I., Gaillard R., Falus A., Rácz K., Igaz P., Integrative molecular bioinformatics study of human adrenocortical tumors: MicroRNA, tissue-specific target prediction, and pathway analysis. Endocrine-Related Cancer 2009 16 3 895 906 2-s2.0-72749126286 10.1677/ERC-09-0096
48. Soon P. S. H., Tacon L. J., Gill A. J., Bambach C. P., Sywak M. S., Campbell P. R., Yeh M. W., Wong S. G., Clifton-Bligh R. J., Robinson B. G., Sidhu S. B., miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clinical Cancer Research 2009 15 24 7684 7692 2-s2.0-73349137922 10.1158/1078-0432.CCR-09-1587
49. Almeida M. Q., Fragoso M. C. B. V., Lotfi C. F. P., Santos M. G., Nishi M. Y., Costa M. H. S., Lerario A. M., Maciel C. C., Mattos G. E., Jorge A. A. L., Mendonca B. B., Latronico A. C., Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 2008 93 9 3524 3531 2-s2.0-51649083560 10.1210/jc.2008-0065
50. Patterson E. E., Holloway A. K., Weng J., Fojo T., Kebebew E., MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer 2011 117 8 1630 1639 2-s2.0-79953767181 10.1002/cncr.25724
51. Schmitz K. J., Helwig J., Bertram S., Sheu S. Y., Suttorp A. C., Seggewiß J., Willscher E., Walz M. K., Worm K., Schmid K. W., Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours. Journal of Clinical Pathology 2011 64 6 529 535 2-s2.0-79956291547 10.1136/jcp.2010.085621
52. Özata D. M., Caramuta S., Velázquez-Fernández D., Akçakaya P., Xie H., Höög A., Zedenius J., Bäckdahl M., Larsson C., Lui W., The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocrine-Related Cancer 2011 18 6 643 655 2-s2.0-84855944292 10.1530/ERC-11-0082
53. Chabre O., Libé R., Assie G., Barreau O., Bertherat J., Bertagna X., Feige J.-J., Cherradi N., Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients. Endocrine-Related Cancer 2013 20 4 579 594 2-s2.0-84882802768 10.1530/ERC-13-0051
54. Faria A. M., Almeida M. Q., Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults. Molecular and Cellular Endocrinology 2012 351 1 52 57 2-s2.0-84857122958 10.1016/j.mce.2011.09.040
55. Doghman M., El Wakil A., Cardinaud B., Thomas E., Wang J., Zhao W., Peralta-Del Valle M. H. C., Figueiredo B. C., Zambetti G. P., Lalli E., Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by MicroRNA in childhood adrenocortical tumors. Cancer Research 2010 70 11 4666 4675 2-s2.0-77953168294 10.1158/0008-5472.CAN-09-3970
56. Lau S. K., Weiss L. M., The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Human Pathology 2009 40 6 757 768 2-s2.0-65149100026 10.1016/j.humpath.2009.03.010
57. Patel D., Boufraqech M., Jain M., MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors. Surgery 2013 154 6 1224 1229
58. Szabo D. R., Luconi M., Szabo P. M., Analysis of circulating microRNAs in adrenocortical tumors. Laboratory Investigation 2014 94 3 331 339
59. Ragazzon B., Libé R., Gaujoux S., Assié G., Fratticci A., Launay P., Clauser E., Bertagna X., Tissier F., de Reyniès A., Bertherat J., Transcriptome analysis reveals that p53 and β -catenin alterations occur in a group of aggressive adrenocortical cancers. Cancer Research 2010 70 21 8276 8281 2-s2.0-78449270065 10.1158/0008-5472.CAN-10-2014